HEADER SIGNALING PROTEIN 03-JUL-23 8PO4 TITLE DISCOVERY AND OPTIMISATION OF POTENT, EFFICACIOUS AND SELECTIVE TITLE 2 INHIBITORS TARGETING EGFR EXON20 INSERTION MUTATIONS. COMPOUND 33 TITLE 3 BOUND TO EGFR[V948R] COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTO-ONCOGENE C-ERBB-1,RECEPTOR TYROSINE-PROTEIN KINASE COMPND 5 ERBB-1; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EGFR, ERBB, ERBB1, HER1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS EGFR, EXON 20 INSERTION, NON-SMALL CELL LUNG CANCER, ONCOLOGY, KEYWDS 2 SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.HARGREAVES REVDAT 2 19-JUN-24 8PO4 1 JRNL REVDAT 1 05-JUN-24 8PO4 0 JRNL AUTH C.THOMSON,P.BARTON,E.BRAYBROOKE,N.COLCLOUGH,Z.DONG,L.EVANS, JRNL AUTH 2 N.FLOC'H,C.GUEROT,D.HARGREAVES,P.KHURANA,S.LI,X.LI,A.LISTER, JRNL AUTH 3 W.MCCOULL,L.MCWILLIAMS,J.P.ORME,M.J.PACKER,A.M.SWAIH, JRNL AUTH 4 R.A.WARD,P.WINLOW,Y.YE JRNL TITL DISCOVERY AND OPTIMIZATION OF POTENT, EFFICACIOUS AND JRNL TITL 2 SELECTIVE INHIBITORS TARGETING EGFR EXON20 INSERTION JRNL TITL 3 MUTATIONS. JRNL REF J.MED.CHEM. V. 67 8988 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38770784 JRNL DOI 10.1021/ACS.JMEDCHEM.4C00227 REMARK 2 REMARK 2 RESOLUTION. 1.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (24-FEB-2021) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.69 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 68.0 REMARK 3 NUMBER OF REFLECTIONS : 66694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 3301 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 22.51 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1272 REMARK 3 BIN R VALUE (WORKING SET) : 0.3017 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.65 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4842 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 341 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.05700 REMARK 3 B22 (A**2) : 0.06370 REMARK 3 B33 (A**2) : -0.12070 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.08020 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.260 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.131 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.125 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.130 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.125 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5019 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6799 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1793 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 834 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5019 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 648 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4339 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.88 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.16 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.11 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8PO4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292131113. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JAN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97623 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 211586 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.621 REMARK 200 RESOLUTION RANGE LOW (A) : 70.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.5 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8K, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 78.24050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.59950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 78.24050 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.59950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 695 REMARK 465 GLY A 696 REMARK 465 GLU A 697 REMARK 465 ALA A 698 REMARK 465 PRO A 699 REMARK 465 GLU A 868 REMARK 465 TYR A 869 REMARK 465 HIS A 870 REMARK 465 ALA A 871 REMARK 465 GLU A 872 REMARK 465 GLY A 873 REMARK 465 GLY A 874 REMARK 465 LYS A 875 REMARK 465 GLU A 1015 REMARK 465 TYR A 1016 REMARK 465 LEU A 1017 REMARK 465 ILE A 1018 REMARK 465 PRO A 1019 REMARK 465 GLN A 1020 REMARK 465 GLN A 1021 REMARK 465 GLY A 1022 REMARK 465 SER B 695 REMARK 465 GLY B 696 REMARK 465 GLU B 697 REMARK 465 ALA B 698 REMARK 465 PRO B 699 REMARK 465 ARG B 748 REMARK 465 GLU B 749 REMARK 465 ALA B 750 REMARK 465 THR B 751 REMARK 465 SER B 752 REMARK 465 PRO B 753 REMARK 465 LYS B 754 REMARK 465 GLY B 863 REMARK 465 ALA B 864 REMARK 465 GLU B 865 REMARK 465 GLU B 866 REMARK 465 LYS B 867 REMARK 465 GLU B 868 REMARK 465 TYR B 869 REMARK 465 HIS B 870 REMARK 465 ALA B 871 REMARK 465 GLU B 872 REMARK 465 GLY B 873 REMARK 465 GLY B 874 REMARK 465 LYS B 875 REMARK 465 GLU B 1015 REMARK 465 TYR B 1016 REMARK 465 LEU B 1017 REMARK 465 ILE B 1018 REMARK 465 PRO B 1019 REMARK 465 GLN B 1020 REMARK 465 GLN B 1021 REMARK 465 GLY B 1022 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 783 -130.62 -129.72 REMARK 500 ASN A 808 -3.61 -164.00 REMARK 500 ARG A 836 -13.79 81.99 REMARK 500 ASP A 837 39.39 -140.25 REMARK 500 MET A1002 10.78 -149.46 REMARK 500 ASP A1003 77.41 -155.39 REMARK 500 THR B 783 -119.91 -121.44 REMARK 500 ARG B 836 -14.85 80.32 REMARK 500 ASP B1003 68.81 -150.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1382 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH A1383 DISTANCE = 8.70 ANGSTROMS REMARK 525 HOH A1384 DISTANCE = 12.11 ANGSTROMS REMARK 525 HOH B1357 DISTANCE = 9.17 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B1102 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 855 OD2 REMARK 620 2 ATP B1101 O2G 88.8 REMARK 620 3 ATP B1101 O2B 172.3 90.3 REMARK 620 4 ATP B1101 O1A 91.2 96.2 96.5 REMARK 620 N 1 2 3 DBREF 8PO4 A 695 1022 UNP P00533 EGFR_HUMAN 695 1022 DBREF 8PO4 B 695 1022 UNP P00533 EGFR_HUMAN 695 1022 SEQADV 8PO4 ARG A 948 UNP P00533 VAL 948 ENGINEERED MUTATION SEQADV 8PO4 ARG B 948 UNP P00533 VAL 948 ENGINEERED MUTATION SEQRES 1 A 328 SER GLY GLU ALA PRO ASN GLN ALA LEU LEU ARG ILE LEU SEQRES 2 A 328 LYS GLU THR GLU PHE LYS LYS ILE LYS VAL LEU GLY SER SEQRES 3 A 328 GLY ALA PHE GLY THR VAL TYR LYS GLY LEU TRP ILE PRO SEQRES 4 A 328 GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA ILE LYS GLU SEQRES 5 A 328 LEU ARG GLU ALA THR SER PRO LYS ALA ASN LYS GLU ILE SEQRES 6 A 328 LEU ASP GLU ALA TYR VAL MET ALA SER VAL ASP ASN PRO SEQRES 7 A 328 HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU THR SER THR SEQRES 8 A 328 VAL GLN LEU ILE THR GLN LEU MET PRO PHE GLY CYS LEU SEQRES 9 A 328 LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN ILE GLY SER SEQRES 10 A 328 GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE ALA LYS GLY SEQRES 11 A 328 MET ASN TYR LEU GLU ASP ARG ARG LEU VAL HIS ARG ASP SEQRES 12 A 328 LEU ALA ALA ARG ASN VAL LEU VAL LYS THR PRO GLN HIS SEQRES 13 A 328 VAL LYS ILE THR ASP PHE GLY LEU ALA LYS LEU LEU GLY SEQRES 14 A 328 ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY GLY LYS VAL SEQRES 15 A 328 PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU HIS ARG SEQRES 16 A 328 ILE TYR THR HIS GLN SER ASP VAL TRP SER TYR GLY VAL SEQRES 17 A 328 THR VAL TRP GLU LEU MET THR PHE GLY SER LYS PRO TYR SEQRES 18 A 328 ASP GLY ILE PRO ALA SER GLU ILE SER SER ILE LEU GLU SEQRES 19 A 328 LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS THR ILE SEQRES 20 A 328 ASP VAL TYR MET ILE MET ARG LYS CYS TRP MET ILE ASP SEQRES 21 A 328 ALA ASP SER ARG PRO LYS PHE ARG GLU LEU ILE ILE GLU SEQRES 22 A 328 PHE SER LYS MET ALA ARG ASP PRO GLN ARG TYR LEU VAL SEQRES 23 A 328 ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SER PRO THR SEQRES 24 A 328 ASP SER ASN PHE TYR ARG ALA LEU MET ASP GLU GLU ASP SEQRES 25 A 328 MET ASP ASP VAL VAL ASP ALA ASP GLU TYR LEU ILE PRO SEQRES 26 A 328 GLN GLN GLY SEQRES 1 B 328 SER GLY GLU ALA PRO ASN GLN ALA LEU LEU ARG ILE LEU SEQRES 2 B 328 LYS GLU THR GLU PHE LYS LYS ILE LYS VAL LEU GLY SER SEQRES 3 B 328 GLY ALA PHE GLY THR VAL TYR LYS GLY LEU TRP ILE PRO SEQRES 4 B 328 GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA ILE LYS GLU SEQRES 5 B 328 LEU ARG GLU ALA THR SER PRO LYS ALA ASN LYS GLU ILE SEQRES 6 B 328 LEU ASP GLU ALA TYR VAL MET ALA SER VAL ASP ASN PRO SEQRES 7 B 328 HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU THR SER THR SEQRES 8 B 328 VAL GLN LEU ILE THR GLN LEU MET PRO PHE GLY CYS LEU SEQRES 9 B 328 LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN ILE GLY SER SEQRES 10 B 328 GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE ALA LYS GLY SEQRES 11 B 328 MET ASN TYR LEU GLU ASP ARG ARG LEU VAL HIS ARG ASP SEQRES 12 B 328 LEU ALA ALA ARG ASN VAL LEU VAL LYS THR PRO GLN HIS SEQRES 13 B 328 VAL LYS ILE THR ASP PHE GLY LEU ALA LYS LEU LEU GLY SEQRES 14 B 328 ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY GLY LYS VAL SEQRES 15 B 328 PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU HIS ARG SEQRES 16 B 328 ILE TYR THR HIS GLN SER ASP VAL TRP SER TYR GLY VAL SEQRES 17 B 328 THR VAL TRP GLU LEU MET THR PHE GLY SER LYS PRO TYR SEQRES 18 B 328 ASP GLY ILE PRO ALA SER GLU ILE SER SER ILE LEU GLU SEQRES 19 B 328 LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS THR ILE SEQRES 20 B 328 ASP VAL TYR MET ILE MET ARG LYS CYS TRP MET ILE ASP SEQRES 21 B 328 ALA ASP SER ARG PRO LYS PHE ARG GLU LEU ILE ILE GLU SEQRES 22 B 328 PHE SER LYS MET ALA ARG ASP PRO GLN ARG TYR LEU VAL SEQRES 23 B 328 ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SER PRO THR SEQRES 24 B 328 ASP SER ASN PHE TYR ARG ALA LEU MET ASP GLU GLU ASP SEQRES 25 B 328 MET ASP ASP VAL VAL ASP ALA ASP GLU TYR LEU ILE PRO SEQRES 26 B 328 GLN GLN GLY HET 26X A1101 36 HET ATP B1101 31 HET MG B1102 1 HETNAM 26X 1-CYCLOPROPYL-~{N}-[3-[1-(1-PROPANOYLAZETIDIN-3-YL)-4- HETNAM 2 26X PYRIDIN-4-YL-PYRAZOL-3-YL]PHENYL]IMIDAZOLE-4- HETNAM 3 26X CARBOXAMIDE HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM MG MAGNESIUM ION FORMUL 3 26X C27 H27 N7 O2 FORMUL 4 ATP C10 H16 N5 O13 P3 FORMUL 5 MG MG 2+ FORMUL 6 HOH *341(H2 O) HELIX 1 AA1 ASN A 700 LEU A 704 5 5 HELIX 2 AA2 LYS A 708 THR A 710 5 3 HELIX 3 AA3 SER A 752 ALA A 767 1 16 HELIX 4 AA4 CYS A 797 HIS A 805 1 9 HELIX 5 AA5 GLY A 810 ARG A 831 1 22 HELIX 6 AA6 ALA A 839 ARG A 841 5 3 HELIX 7 AA7 GLY A 857 LEU A 862 1 6 HELIX 8 AA8 PRO A 877 MET A 881 5 5 HELIX 9 AA9 ALA A 882 ARG A 889 1 8 HELIX 10 AB1 THR A 892 THR A 909 1 18 HELIX 11 AB2 PRO A 919 SER A 921 5 3 HELIX 12 AB3 GLU A 922 LYS A 929 1 8 HELIX 13 AB4 THR A 940 TRP A 951 1 12 HELIX 14 AB5 ASP A 954 ARG A 958 5 5 HELIX 15 AB6 LYS A 960 ARG A 973 1 14 HELIX 16 AB7 ASP A 974 TYR A 978 5 5 HELIX 17 AB8 GLY A 983 MET A 987 5 5 HELIX 18 AB9 SER A 991 ASP A 1003 1 13 HELIX 19 AC1 ASN B 700 LEU B 704 5 5 HELIX 20 AC2 LYS B 708 THR B 710 5 3 HELIX 21 AC3 ASN B 756 SER B 768 1 13 HELIX 22 AC4 CYS B 797 HIS B 805 1 9 HELIX 23 AC5 LYS B 806 ILE B 809 5 4 HELIX 24 AC6 GLY B 810 ARG B 831 1 22 HELIX 25 AC7 ALA B 839 ARG B 841 5 3 HELIX 26 AC8 GLY B 857 LEU B 862 1 6 HELIX 27 AC9 PRO B 877 MET B 881 5 5 HELIX 28 AD1 ALA B 882 ARG B 889 1 8 HELIX 29 AD2 THR B 892 THR B 909 1 18 HELIX 30 AD3 PRO B 919 SER B 921 5 3 HELIX 31 AD4 GLU B 922 LYS B 929 1 8 HELIX 32 AD5 THR B 940 TRP B 951 1 12 HELIX 33 AD6 ASP B 954 ARG B 958 5 5 HELIX 34 AD7 LYS B 960 ASP B 974 1 15 HELIX 35 AD8 PRO B 975 TYR B 978 5 4 HELIX 36 AD9 GLY B 983 MET B 987 5 5 HELIX 37 AE1 SER B 991 ASP B 1003 1 13 SHEET 1 AA1 6 ARG A 705 ILE A 706 0 SHEET 2 AA1 6 GLY A 779 LEU A 782 1 O ILE A 780 N ARG A 705 SHEET 3 AA1 6 VAL A 786 THR A 790 -1 O ILE A 789 N GLY A 779 SHEET 4 AA1 6 ILE A 740 LEU A 747 -1 N LEU A 747 O VAL A 786 SHEET 5 AA1 6 GLY A 724 TRP A 731 -1 N TRP A 731 O ILE A 740 SHEET 6 AA1 6 PHE A 712 SER A 720 -1 N ILE A 715 O LYS A 728 SHEET 1 AA2 2 VAL A 843 THR A 847 0 SHEET 2 AA2 2 HIS A 850 ILE A 853 -1 O LYS A 852 N LEU A 844 SHEET 1 AA3 6 ARG B 705 ILE B 706 0 SHEET 2 AA3 6 GLY B 779 LEU B 782 1 O ILE B 780 N ARG B 705 SHEET 3 AA3 6 VAL B 786 THR B 790 -1 O ILE B 789 N GLY B 779 SHEET 4 AA3 6 ILE B 740 GLU B 746 -1 N LYS B 745 O LEU B 788 SHEET 5 AA3 6 THR B 725 TRP B 731 -1 N TRP B 731 O ILE B 740 SHEET 6 AA3 6 PHE B 712 SER B 720 -1 N GLY B 719 O VAL B 726 SHEET 1 AA4 2 VAL B 843 THR B 847 0 SHEET 2 AA4 2 HIS B 850 ILE B 853 -1 O LYS B 852 N LEU B 844 LINK SG CYS A 797 C 26X A1101 1555 1555 1.75 LINK OD2 ASP B 855 MG MG B1102 1555 1555 2.02 LINK O2G ATP B1101 MG MG B1102 1555 1555 1.98 LINK O2B ATP B1101 MG MG B1102 1555 1555 2.01 LINK O1A ATP B1101 MG MG B1102 1555 1555 2.02 CRYST1 156.481 71.199 76.543 90.00 113.00 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006391 0.000000 0.002713 0.00000 SCALE2 0.000000 0.014045 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014193 0.00000